Stay updated on Guselkumab in Psoriasis: Clinical Trial
Sign up to get notified when there's something new on the Guselkumab in Psoriasis: Clinical Trial page.

Latest updates to the Guselkumab in Psoriasis: Clinical Trial page
- Check4 days agoChange Detected- Revision updated to v3.5.0, replacing the previous v3.4.3. - This appears to be a software/update change with no visible edits to study details or user-facing content.SummaryDifference0.0%

- Check11 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check40 days agoChange DetectedMinimal site update detected: Revision: v3.4.2 was added and the government funding lapse notice was removed. No changes were made to study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check47 days agoChange DetectedAdded a government funding notice about potential delays in updating information and site operations. Updated the site revision tag to v3.4.1, replacing v3.4.0.SummaryDifference0.2%

- Check54 days agoChange DetectedShow glossary has been added to the page, and the QC-related metadata has been updated to display 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', along with a revision note 'Revision: v3.4.0'. These changes are minor UI and wording updates and do not alter the study content, eligibility criteria, or results.SummaryDifference0.1%

- Check68 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4, indicating a minor update to the page. No study data, eligibility criteria, or results appear to be affected.SummaryDifference0.0%

Stay in the know with updates to Guselkumab in Psoriasis: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Guselkumab in Psoriasis: Clinical Trial page.